Does Rallies track congressional trades in RVTY?

Yes. Rallies tracks politician and congressional stock disclosures for RVTY, including reported purchases, sales, dates, owners, and trade amounts when available.

Is RVTY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RVTY. It does not provide personalized investment advice.

RVTY (Revvity, Inc.) Stock Analysis - Politician Trades

Revvity, Inc. (RVTY) is a publicly traded Healthcare sector company. As of May 20, 2026, RVTY trades at $94.89 with a market cap of $10.65B and a P/E ratio of 46.01. RVTY moved -0.97% today. Year to date, RVTY is -7.11%; over the trailing twelve months it is +1.30%. Its 52-week range spans $81.22 to $129.50. Analyst consensus is buy with an average price target of $104.75. Rallies surfaces RVTY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded RVTY stock?

Recent politician trading activity in RVTY includes disclosures from Gilbert Cisneros, Gilbert Cisneros, Gilbert Cisneros, Gilbert Cisneros, and John Delaney. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

RVTY Key Metrics

Key financial metrics for RVTY
Metric	Value
Price	$94.89
Market Cap	$10.65B
P/E Ratio	46.01
EPS	$2.07
Dividend Yield	0.07%
52-Week High	$129.50
52-Week Low	$81.22
Volume	1.05M
Avg Volume	0
Revenue (TTM)	$2.86B
Net Income	$241.20M
Gross Margin	0.00%

Congressional Trades in RVTY

Gilbert Cisneros purchase RVTY on Sep 12, 2025 (amount: $15.00K).
Gilbert Cisneros purchase RVTY on Jul 23, 2025 (amount: $15.00K).
Gilbert Cisneros purchase RVTY on Jun 11, 2025 (amount: $15.00K).
Gilbert Cisneros purchase RVTY on May 28, 2025 (amount: $15.00K).
John Delaney sale RVTY on Feb 28, 2025 (amount: $50.00K).

Latest RVTY News

Revvity jumps after Q1 EPS beat as investors look past lowered 2026 outlook — May 6, 2026
Revvity jumps as Q1 EPS beats and China immunodiagnostics divestiture unveiled — May 5, 2026
Revvity jumps as Signals BioDesign launch spotlights software growth ahead of earnings — Apr 30, 2026
Revvity slides ahead of May 5 earnings as growth outlook faces scrutiny — Apr 29, 2026
Revvity drops nearly 8% as investors de-risk ahead of May 5 earnings — Apr 23, 2026

Recent RVTY Insider Trades

Gonzales Anita sold 80 (~$7.42K) on Apr 20, 2026.
Victor Miriame sold 1.86K (~$180.86K) on Feb 24, 2026.
McMurry-Heath Michelle sold 600 (~$58.36K) on Feb 23, 2026.

RVTY Analyst Consensus

10 analysts cover RVTY: 0 strong buy, 3 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $104.75.

Common questions about RVTY

Which politicians traded RVTY stock?: Recent politician trading activity in RVTY includes disclosures from Gilbert Cisneros, Gilbert Cisneros, Gilbert Cisneros, Gilbert Cisneros, and John Delaney. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in RVTY?: Yes. Rallies tracks politician and congressional stock disclosures for RVTY, including reported purchases, sales, dates, owners, and trade amounts when available.
Is RVTY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RVTY. It does not provide personalized investment advice.